ReP USP - Resultado da busca

Filtros : "European Journal of Pharmaceutics and Biopharmaceutics" "IQSC" Limpar

Filtros

Artigo de periodico
Self-assembled amphiphilic chitosan nanoparticles for quercetin delivery to breast cancer cells (2018)
Pedro, Rafael de Oliveira; Hoffmann, Stephan; Pereira, Susana; Goycoolea, Francisco M; Cavalheiro, Carla Cristina Schmitt ; Neumann, Miguel Guillermo
Source: European Journal of Pharmaceutics and Biopharmaceutics. Unidade: IQSC
Assunto: QUITOSANA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEDRO, Rafael de Oliveira et al. Self-assembled amphiphilic chitosan nanoparticles for quercetin delivery to breast cancer cells. European Journal of Pharmaceutics and Biopharmaceutics, v. 131, p. 203-210, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2018.08.009. Acesso em: 18 nov. 2024.
APA
Pedro, R. de O., Hoffmann, S., Pereira, S., Goycoolea, F. M., Cavalheiro, C. C. S., & Neumann, M. G. (2018). Self-assembled amphiphilic chitosan nanoparticles for quercetin delivery to breast cancer cells. European Journal of Pharmaceutics and Biopharmaceutics, 131, 203-210. doi:10.1016/j.ejpb.2018.08.009
NLM
Pedro R de O, Hoffmann S, Pereira S, Goycoolea FM, Cavalheiro CCS, Neumann MG. Self-assembled amphiphilic chitosan nanoparticles for quercetin delivery to breast cancer cells [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2018 ;131203-210.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.ejpb.2018.08.009
Vancouver
Pedro R de O, Hoffmann S, Pereira S, Goycoolea FM, Cavalheiro CCS, Neumann MG. Self-assembled amphiphilic chitosan nanoparticles for quercetin delivery to breast cancer cells [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2018 ;131203-210.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.ejpb.2018.08.009
Artigo de periodico
Alginate hydrogel improves anti-angiogenic bevacizumab activity in cancer therapy (2017)
Ferreira, Natália N.; Ferreira, Leonardo Mortensen Nunes; Miranda-Gonçalves, Vera; Reis, Rui Manuel ; Seraphim, Thiago Vargas ; Borges, Julio Cesar ; Baltazar, Fátima ; Gremiao, Maria Palmira Daflon
Source: European Journal of Pharmaceutics and Biopharmaceutics. Unidade: IQSC
Subjects: BIOLOGIA CELULAR, PROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Natália N. et al. Alginate hydrogel improves anti-angiogenic bevacizumab activity in cancer therapy. European Journal of Pharmaceutics and Biopharmaceutics, v. 119, p. 271-282, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2017.06.028. Acesso em: 18 nov. 2024.
APA
Ferreira, N. N., Ferreira, L. M. N., Miranda-Gonçalves, V., Reis, R. M., Seraphim, T. V., Borges, J. C., et al. (2017). Alginate hydrogel improves anti-angiogenic bevacizumab activity in cancer therapy. European Journal of Pharmaceutics and Biopharmaceutics, 119, 271-282. doi:10.1016/j.ejpb.2017.06.028
NLM
Ferreira NN, Ferreira LMN, Miranda-Gonçalves V, Reis RM, Seraphim TV, Borges JC, Baltazar F, Gremiao MPD. Alginate hydrogel improves anti-angiogenic bevacizumab activity in cancer therapy [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2017 ; 119 271-282.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.ejpb.2017.06.028
Vancouver
Ferreira NN, Ferreira LMN, Miranda-Gonçalves V, Reis RM, Seraphim TV, Borges JC, Baltazar F, Gremiao MPD. Alginate hydrogel improves anti-angiogenic bevacizumab activity in cancer therapy [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2017 ; 119 271-282.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.ejpb.2017.06.028

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024